Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeo Fuji

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
Transplantation and Cellular Therapy|August 30, 2025
Allogeneic hematopoietic stem cell transplantation for older patients with adult T-cell leukemia/lymphoma: A nationwide retrospective studyHikaru Sakamoto, Yasushi Sawayama, Shigeo Fuji, et al.
Transplantation and Cellular Therapy|July 18, 2021
A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/LymphomaTakashi Tanaka, Hirohisa Nakamae, Ayumu Ito, et al.
Blood Advances|June 17, 2026
WT1 peptide vaccines of post-allogeneic HSCT maintenance immunotherapy for pediatric acute leukemias: a phase II studyYoshiko Hashii, Yoshihiro Oka, Naoki Sakata, et al.
Bone Marrow Transplantation|September 4, 2021
Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell TransplantationShigeo Fuji, Akitoshi Hakoda, Junya Kanda, et al.
Bone Marrow Transplantation|January 21, 2023
Cord blood is a suitable donor source of allogeneic hematopoietic cell transplantation for adult T-cell leukemia-lymphoma: a nationwide retrospective studyMasahito Tokunaga, Nobuaki Nakano, Shigeo Fuji, et al.
Bone Marrow Transplantation|February 3, 2025
Significant detrimental impact of pre-transplant mogamulizumab on the post-transplant outcome with a short interval between the last mogamulizumab and transplantationShigeo Fuji, Masahito Tokunaga, Koji Kato, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 8, 2025
Prognostic Impact of Cytomegalovirus Reactivation After Transplantation From Cord Blood Compared to Other Donor Sources in Patients With Adult T-Cell Leukemia/Lymphoma in the Pre-Letermovir EraTakuya Fukushima, Hidehiro Itonaga, Hikaru Sakamoto, et al.
Blood Advances|January 26, 2021
Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCTNobuaki Nakano, Atae Utsunomiya, Keitaro Matsuo, et al.
The Lancet Regional Health. Western Pacific|December 18, 2023
Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national surveyNobuaki Nakano, Hideki Nakasone, Shigeo Fuji, et al.
British Journal of Haematology|June 16, 2026
Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experienceHidehiro Itonaga, Takuya Fukushima, Koji Kato, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Transplantation and Cellular Therapy|August 30, 2025
Allogeneic hematopoietic stem cell transplantation for older patients with adult T-cell leukemia/lymphoma: A nationwide retrospective studyHikaru Sakamoto, Yasushi Sawayama, Shigeo Fuji, et al.
Transplantation and Cellular Therapy|July 18, 2021
A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/LymphomaTakashi Tanaka, Hirohisa Nakamae, Ayumu Ito, et al.
Blood Advances|June 17, 2026
WT1 peptide vaccines of post-allogeneic HSCT maintenance immunotherapy for pediatric acute leukemias: a phase II studyYoshiko Hashii, Yoshihiro Oka, Naoki Sakata, et al.
Bone Marrow Transplantation|September 4, 2021
Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell TransplantationShigeo Fuji, Akitoshi Hakoda, Junya Kanda, et al.
Bone Marrow Transplantation|January 21, 2023
Cord blood is a suitable donor source of allogeneic hematopoietic cell transplantation for adult T-cell leukemia-lymphoma: a nationwide retrospective studyMasahito Tokunaga, Nobuaki Nakano, Shigeo Fuji, et al.
Bone Marrow Transplantation|February 3, 2025
Significant detrimental impact of pre-transplant mogamulizumab on the post-transplant outcome with a short interval between the last mogamulizumab and transplantationShigeo Fuji, Masahito Tokunaga, Koji Kato, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 8, 2025
Prognostic Impact of Cytomegalovirus Reactivation After Transplantation From Cord Blood Compared to Other Donor Sources in Patients With Adult T-Cell Leukemia/Lymphoma in the Pre-Letermovir EraTakuya Fukushima, Hidehiro Itonaga, Hikaru Sakamoto, et al.
Blood Advances|January 26, 2021
Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCTNobuaki Nakano, Atae Utsunomiya, Keitaro Matsuo, et al.
The Lancet Regional Health. Western Pacific|December 18, 2023
Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national surveyNobuaki Nakano, Hideki Nakasone, Shigeo Fuji, et al.
British Journal of Haematology|June 16, 2026
Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experienceHidehiro Itonaga, Takuya Fukushima, Koji Kato, et al.
Pageof 20